Information

Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

Epigenome replication

back to job offer list

back to clinical trials

(Epi)genome replication: research topics

This team belongs to the UMR 9019 Genome Integrity and Cancers.

Our goal is to understand how cells copy both their DNA and epigenome during division. Disruptions in this process can lead to changes in cell identity and contribute to cancer.

Rapport intégré 2022 -2023

back to job offer list

back to clinical trials

Repères 2023

back to job offer list

back to clinical trials

Attestation CER 2022

back to job offer list

back to clinical trials

Fondation Gustave Roussy - Rapport du commissaire aux comptes 2022

back to job offer list

back to clinical trials

ESMO 2024 - personalised treatments for soft tissue sarcomas

back to job offer list

back to clinical trials

ESMO 2024 – Proffered Paper Session

Villejuif, 16 September 2024

ESMO 2024 - A new medically promising antibody conjugate for metastatic breast cancer

back to job offer list

back to clinical trials

ESMO 2024 – Proffered Paper Session

Villejuif, 13 September 2024

ESMO 2024 - New hope in the treatment of thymus gland cancers

back to job offer list

back to clinical trials

ESMO 2024 – Proffered Paper Session

Villejuif, 13 September 2024

09/11/2024

Gustave Roussy at ESMO Congress 2024

Bringing together more than 31,000 international experts, the European Society of Medical Oncology (ESMO) annual congress is one of the highlights of global oncology. This year, it will be held from 13 to 17 September in Barcelona. Gustave Roussy, the leading cancer research and treatment centre in France and Europe, ranked fourth globally, is one...